Table 2. Comparison of clinical, laboratory and HIV-infection characteristics between patients with and without CKD.
| VARIABLES | No CKD | eGFR < 60 mL/min | Albuminuria (Alb) | eGFR < 60 mL/min + Alb | p | ||||
|---|---|---|---|---|---|---|---|---|---|
| n = 242 | % | n = 11 | % | n = 12 | % | n = 9 | % | ||
| Age (years) | 40 ± 11a | 51 ± 10 | 35 ± 10b,c,d | 49 ± 9d | 0.001 | ||||
| Female | 67 | 27.7% | 3 | 27.3% | 3 | 25.0% | 3 | 33.3% | 0.98 |
| Male | 175 | 72.3% | 8 | 72.7% | 9 | 75.0% | 6 | 66.7% | |
| Smoking | 70 | 28.9% | 3 | 27.3% | 2 | 16.7% | 3 | 33.3% | 0.81 |
| Drug use | 36 | 14.9% | 1 | 9.1% | 1 | 8.3% | 2 | 22.2% | 0.78 |
| Hypertension | 16 | 6.6% | 2 | 18.2% | 1 | 8.3% | 2 | 22.2% | 0.18 |
| Diabetes mellitus 2 | 18 | 7.4% | 0 | 0.0% | 0 | 0.0% | 1 | 11.1% | 0.56 |
| HIV viral load | 88,937 ± 253,253 | 110,339 ± 187,174 | 29,086 ± 52,838 | 151,196 ± 239,386 | 0,71 | ||||
| CD4 count | 371 ± 275 | 279 ± 167 | 407 ± 378 | 362 ± 294 | 0,70 | ||||
| Clinical HIV category | |||||||||
| A | 71 | 29.3% | 2 | 18.2% | 6 | 50.0% | 0 | 0,0% | 0.26 |
| B | 94 | 38.8% | 6 | 54.5% | 4 | 33.3% | 5 | 55.6% | |
| C | 77 | 31.8% | 3 | 27.3% | 2 | 16.7% | 4 | 44.4% | |
| Inmunological HIV category | |||||||||
| 1 | 40 | 16.5% | 2 | 18.2% | 3 | 25,0% | 0 | 0,0% | 0.43 |
| 2 | 102 | 42.1% | 4 | 36.4% | 7 | 58.3% | 6 | 66.7% | |
| 3 | 100 | 41.3% | 5 | 45.5% | 2 | 16.7% | 3 | 33.3% | |
| HBV Positive | 1 | 0.4% | 1 | 9.1%a | 0 | 0.0% | 0 | 0.0% | 0.01 |
| HCV Positive | 7 | 2.9% | 1 | 9.1% | 0 | 0.0% | 0 | 0.0% | 0.55 |
| VDRL Positive | 10 | 4.1% | 1 | 9.1% | 1 | 8.3% | 1 | 11.1% | 0.61 |
HIV= human inmodeficiency virus; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; HBV: hepatitis B virus; HCV: hepatitis C virus; VDRL: venereal disease research laboratory.
No CKD vs. eGFR < 60 ml/min;
albuminuria vs. No CKD;
albuminuria vs. eGFR< 60 ml/min;
albuminuria vs. eGFR< 60 ml/min + Albuminuria.